Lidocaine Hci Injection, Solution
Product Images NDC 51662-1232

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Desc Tabel (Desc Tabel 1)

Desc Tabel (Desc Tabel 1)
A data table presenting concentrations of Lidocaine HCl with corresponding values of epinephrine ratios, lidocaine HCl in mg/mL, epinephrine in mcg/mL, and sodium chloride in mg/mL. It lists various combinations including 0.5% to 2% lidocaine with epinephrine ratios of 1:200,000 and 1:100,000.*
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure diagram of Lidocaine HCl, showing the molecular formula with methyl groups, amide linkage, diethylamino group, hydrochloride, and water of hydration components.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure of lidocaine HCl, showing a benzene ring with two hydroxyl groups and a side chain containing a hydroxyl and an amine group.*
FDA Label Image

How Supplied Tabel (How Supplied Table)

How Supplied Tabel (How Supplied Table)
Table listing various NDC numbers, container types, sizes, and drug concentrations for Lidocaine HCl injection solutions with Epinephrine. It shows single-dose and multiple-dose flitop vials and ampuls, with Lidocaine HCl concentrations ranging from 0.5% to 2%, and Epinephrine concentrations of 1:200,000 or 1:100,000.*
FDA Label Image
FDA Label Image

Dosage Tabel 1 (Dosage 1)

Dosage Tabel 1 (Dosage 1)
A table titled 'Recommended Dosages Lidocaine Hydrochloride Injection, USP (without Epinephrine)' presenting dosage guidelines by procedure type. It lists concentration percentages, volume in mL, and total dose in mg for infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, including specific procedures such as brachial, dental, epidural, and others.*
FDA Label Image

Label (51662 1232 1)

Label (51662 1232 1)
QR code label for LIDOCAINE HCI injection solution showing GS1 barcoded numbers and text instructing to see the manufacturer's insert. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label includes an RX ONLY designation.*
FDA Label Image

Pouch Labeling (51662123225 Lidocaine Pouch Label V2)

Pouch Labeling (51662123225 Lidocaine Pouch Label V2)
Label for Lidocaine HCl 1% and Epinephrine 1:100,000 Injection, USP in a 20 mL vial. The label shows NDC 51662-1232-2, lot number HF100809292020, and expiration date 2020-09-29. It includes storage instructions, usage warnings, and manufacturer information for HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Case Labeling (51662123232 Lidocaine Hci Case Label)

Case Labeling (51662123232 Lidocaine Hci Case Label)
Label for Lidocaine HCl 1% and Epinephrine 1:100,000 injection, USP in 20 mL vial, pack of 25. The label includes the NDC 51662-1232-3, lot number 12345, and an expiration date of June 30, 2030. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*
FDA Label Image

Rfid Label (51662 1232 3 Rfid)

Rfid Label (51662 1232 3 Rfid)
Close-up of a label on a LIDOCAINE HCI injection solution package distributed by HF Acquisition Co LLC, Mukilteo, WA. The label includes identification codes, a barcode, and the instruction to see the manufacturer's insert for details.*
FDA Label Image

Revised Vial Labeling (51662 1232 2 Revised Vial Labeling)

Revised Vial Labeling (51662 1232 2 Revised Vial Labeling)
Label for Lidocaine HCl 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP, 20 mL multiple-dose vial. Indicated for infiltration and nerve block, marked as prescription only and not for epidural or caudal use. Distributed by Hospira, Inc., Lake Forest, IL. Contains detailed ingredient information and usage instructions.*
FDA Label Image

51662-1232-3 Revised Vial Labeling (51662 1232 3 Revised Vial Labeling)

51662-1232-3 Revised Vial Labeling (51662 1232 3 Revised Vial Labeling)
Label for Lidocaine HCl 1% Injection with Epinephrine 1:100,000, 10 mg/mL, 20 mL multiple-dose vial. The label indicates use for infiltration and nerve block, not for epidural or caudal use. Distributed by Hospira, Inc., Lake Forest, IL, USA, with NDC 0409-3178-16. It includes storage and handling instructions and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.